Vimarsana
Biggest News Aggregation in the World

Page 40 - Mployee Wellness Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mployee Wellness Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mployee Wellness Programs Today - Breaking & Trending Today

Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024 - Vimarsana News

Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024

CG Oncology’s upsized IPO will support pivotal testing of cretostimogene, an oncolytic virus for non-muscle invasive bladder cancer. The clinical program spans tests of the engineered virus as a monotherapy and as part of combination treatments.

Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models - Vimarsana News

Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models

Despite the significant challenges to improving U.S. health outcomes while reducing healthcare spending, I am heartened by the exciting ways in which government organizations and the private sector are innovating and deploying new technologies that can achieve these goals.

Key Trends from the 2024J.P. Morgan Healthcare Conference - Vimarsana News

Key Trends from the 2024J.P. Morgan Healthcare Conference

Key trends such as the resilience of the emerging biopharma space, the complexities of Medicare, and the revolutionary role of data and AI are shaping the future of the industry.

Inside California's Free Digital Health Platforms Supporting Child Mental Health - Vimarsana News

Inside California's Free Digital Health Platforms Supporting Child Mental Health

The California Department of Health Care Services launched the Behavioral Health Virtual Services Platform last week. The platform includes two digital health solutions: BrightLife Kids (developed by Brightline) for parents/caregivers and kids ages 0 to 12 and Soluna (developed by Kooth) for teens and young adults ages 13 to 25.

FDA Calls for New Safety Warning for the Class of CAR T Cancer Therapies - Vimarsana News

FDA Calls for New Safety Warning for the Class of CAR T Cancer Therapies

Two months after announcing an inquiry into reports of new cancers in patients treated with CAR T-cell therapies, the FDA is directing makers of these therapies to add new safety warnings to product labels describing this risk. Companies have 30 calendar days to comply.